Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2015 Dec 6;71(Pt 12):o1010–o1011. doi: 10.1107/S2056989015022884

Crystal structure of (Z)-3-allyl-5-(3-bromo­benzyl­idene)-2-sulfanyl­idene-1,3-thia­zolidin-4-one

Rahhal El Ajlaoui a,*, El Mostapha Rakib a, Issam Forsal a, Mohamed Saadi b, Lahcen El Ammari b
PMCID: PMC4719950  PMID: 26870469

Abstract

In the title compound, C13H10BrNOS2, the rhodanine (systematic name: 2-sulfanyl­idene-1,3-thia­zolidin-4-one) and the 3-bromo­benzyl­idene ring systems are inclined slightly, forming a dihedral angle of 5.86 (12)°. The rhodanine moiety is linked to an allyl group at the N atom and to the 3-bromo­benzyl­idene ring system. The allyl group, C=C—C, is nearly perpendicular to the mean plane through the rhodanine ring, maling a dihedral angle of 87.2 (5)°. In the crystal, mol­ecules are linked by pairs of C—H⋯O hydrogen bonds, forming inversion dimers with an R 2 2(10) ring motif.

Keywords: crystal structure, rhodanine, hydrogen bonding

Related literature  

For pharmacological and biological activities of rhodanine-based mol­ecules, see: Tomasić & Masic (2009); Sortino et al. (2007); Kesel (2003); Capan et al. (1996); Momose et al. (1991); Kawakami et al. (1998); Insuasty et al. (2010). For the crystal structure of a related compound, see: El Ajlaoui et al. (2015).graphic file with name e-71-o1010-scheme1.jpg

Experimental  

Crystal data  

  • C13H10BrNOS2

  • M r = 340.25

  • Triclinic, Inline graphic

  • a = 5.4044 (6) Å

  • b = 11.2306 (13) Å

  • c = 11.7966 (13) Å

  • α = 80.100 (5)°

  • β = 84.912 (6)°

  • γ = 76.732 (6)°

  • V = 685.60 (13) Å3

  • Z = 2

  • Mo Kα radiation

  • μ = 3.29 mm−1

  • T = 296 K

  • 0.31 × 0.27 × 0.21 mm

Data collection  

  • Bruker X8 APEX diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2009) T min = 0.479, T max = 0.746

  • 25482 measured reflections

  • 4181 independent reflections

  • 2895 reflections with I > 2σ(I)

  • R int = 0.044

Refinement  

  • R[F 2 > 2σ(F 2)] = 0.039

  • wR(F 2) = 0.098

  • S = 1.01

  • 4181 reflections

  • 163 parameters

  • H-atom parameters constrained

  • Δρmax = 0.95 e Å−3

  • Δρmin = −0.71 e Å−3

Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXS2014 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: ORTEPIII (Burnett & Johnson, 1996), ORTEP-3 for Windows (Farrugia, 2012) and PLATON (Spek, 2009); software used to prepare material for publication: publCIF (Westrip, 2010).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249sup1.cif

e-71-o1010-sup1.cif (785.6KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249Isup2.hkl

e-71-o1010-Isup2.hkl (333.1KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015022884/su5249Isup3.cml

. DOI: 10.1107/S2056989015022884/su5249fig1.tif

A view of the mol­ecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

a . DOI: 10.1107/S2056989015022884/su5249fig2.tif

A view along the a axis of the crystal packing of the title compound, showing the hydrogen bonds as dashed lines (see Table 1).

CCDC reference: 1439611

Additional supporting information: crystallographic information; 3D view; checkCIF report

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
C7—H7⋯O1i 0.93 2.42 3.310 (3) 159

Symmetry code: (i) Inline graphic.

Acknowledgments

The authors thank the Unit of Support for Technical and Scientific Research (UATRS, CNRST) for the X-ray measurements and the University Sultan Moulay Slimane, Beni-Mellal, Morocco, for financial support.

supplementary crystallographic information

S1. Structural commentary

Rhodanine is an attractive scaffold unit because of its prestigious position in medicinal chemistry as it is responsible for numerous pharmacological and biological activities (Tomasic & Masic, 2009), e.g., anti­microbial, anti­viral, anti­convulsant, anti­diabetic and anti­tumor activities (Sortino et al., 2007; Kesel, 2003; Capan et al., 1996; Momose et al., 1991; Kawakami et al., 1998; Insuasty et al. 2010). The unusual biological activity displayed by many rhodanine-based molecules have made them attractive synthetic targets.

The title compound, Fig. 1, is build up from a rhodanine ring (S1/N/1 C8–C10) linked to an allyl group (C11–C13) at the nitro­gen atom and to a 3-bromo­benzyl­idene ring system (C1—C6). The mean plane through the rhodanine ring is almost perpendicular to the allyl group (C11—C13) with a dihedral angle of 87.2 (5) °, and makes a dihedral angle of 5.86 (12)° with the 3-bromo­benzyl­idene ring. A very similar arrangement has been observed in the crystal structure of (Z)-3-allyl-5-(4-methyl-benzyl­idene)-2-thioxo­thia­zolidin-4-one, but with disorder in the allyl group (El Ajlaoui et al., 2015).

In the crystal, molecules are linked by a pair of C—H···O hydrogen bonds forming inversion dimers with an R22(10) ring motif (Table 1 and Fig. 2).

S2. Synthesis and crystallization

To a solution of 3-allyl­rhodanine (1.15 mmol, 0.2 g) in 10 ml of THF, (3-bromo­benzyl­idene)-4-methyl-5-oxopyrazolidin-2-ium-1-ide (1.38 mmol) was added and the mixture refluxed for 8 h, monitored by TLC. On completion of the reaction, with a yellow spot (TLC Rf = 0.3, using hexane/ethyl acetate 1:9) generated cleanly, the solvent was evaporated in vacuo. The crude product was purified on silica gel using hexane:ethyl acetate (1:9) as eluent. The title compound was recrystallized from ethanol giving colourless block-like crystals (yield: 76%; m.p. 390 K).

S3. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2. H atoms were located in a difference Fourier map and treated as riding: C–H = 0.93–0.97 Å with Uiso(H) = 1.2Ueq(C). Two reflections, (0 1 0) and (0 0 1), affected by the beam-stop were removed during the final cycles of refinement.

Figures

Fig. 1.

Fig. 1.

A view of the molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

Fig. 2.

Fig. 2.

A view along the a axis of the crystal packing of the title compound, showing the hydrogen bonds as dashed lines (see Table 1).

Crystal data

C13H10BrNOS2 F(000) = 340
Mr = 340.25 Dx = 1.648 Mg m3
Triclinic, P1 Melting point: 390 K
a = 5.4044 (6) Å Mo Kα radiation, λ = 0.71073 Å
b = 11.2306 (13) Å Cell parameters from 4181 reflections
c = 11.7966 (13) Å θ = 2.8–30.5°
α = 80.100 (5)° µ = 3.29 mm1
β = 84.912 (6)° T = 296 K
γ = 76.732 (6)° Block, colourless
V = 685.60 (13) Å3 0.31 × 0.27 × 0.21 mm
Z = 2

Data collection

Bruker X8 APEX diffractometer 4181 independent reflections
Radiation source: fine-focus sealed tube 2895 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.044
φ and ω scans θmax = 30.5°, θmin = 2.8°
Absorption correction: multi-scan (SADABS; Bruker, 2009) h = −7→7
Tmin = 0.479, Tmax = 0.746 k = −16→16
25482 measured reflections l = −16→16

Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.039 H-atom parameters constrained
wR(F2) = 0.098 w = 1/[σ2(Fo2) + (0.0356P)2 + 0.492P] where P = (Fo2 + 2Fc2)/3
S = 1.01 (Δ/σ)max = 0.001
4181 reflections Δρmax = 0.95 e Å3
163 parameters Δρmin = −0.71 e Å3

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
C1 0.7585 (5) 0.8474 (2) 0.6704 (2) 0.0449 (5)
C2 0.7277 (6) 0.8621 (3) 0.5535 (2) 0.0578 (7)
H2 0.7974 0.9201 0.5025 0.069*
C3 0.5914 (6) 0.7891 (3) 0.5138 (2) 0.0625 (8)
H3 0.5704 0.7977 0.4352 0.075*
C4 0.4861 (5) 0.7039 (3) 0.5885 (2) 0.0516 (6)
H4 0.3934 0.6562 0.5601 0.062*
C5 0.5173 (4) 0.6882 (2) 0.70721 (19) 0.0379 (5)
C6 0.6565 (4) 0.7623 (2) 0.7469 (2) 0.0392 (5)
H6 0.6799 0.7540 0.8253 0.047*
C7 0.4177 (4) 0.5987 (2) 0.79133 (19) 0.0386 (5)
H7 0.4638 0.5940 0.8663 0.046*
C8 0.2693 (4) 0.5212 (2) 0.77866 (18) 0.0358 (4)
C9 0.1983 (4) 0.4349 (2) 0.87829 (19) 0.0402 (5)
C10 −0.0140 (4) 0.3884 (2) 0.7315 (2) 0.0385 (5)
C11 −0.0559 (5) 0.2749 (3) 0.9303 (2) 0.0538 (7)
H11A −0.2218 0.2691 0.9094 0.065*
H11B −0.0769 0.3018 1.0051 0.065*
C12 0.1173 (8) 0.1500 (3) 0.9393 (3) 0.0717 (9)
H12 0.0739 0.0898 0.9972 0.086*
C13 0.3193 (8) 0.1155 (3) 0.8769 (3) 0.0845 (11)
H13A 0.3724 0.1716 0.8176 0.101*
H13B 0.4125 0.0343 0.8909 0.101*
N1 0.0372 (4) 0.36716 (18) 0.84606 (16) 0.0398 (4)
O1 0.2673 (4) 0.42021 (19) 0.97577 (14) 0.0579 (5)
S1 0.13666 (12) 0.50102 (6) 0.65523 (5) 0.04169 (14)
S2 −0.18899 (14) 0.31940 (7) 0.67061 (6) 0.05491 (18)
Br1 0.94248 (6) 0.94874 (3) 0.72543 (3) 0.06670 (13)

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
C1 0.0478 (14) 0.0440 (13) 0.0461 (13) −0.0140 (11) −0.0009 (10) −0.0110 (10)
C2 0.0697 (18) 0.0600 (17) 0.0465 (14) −0.0269 (14) 0.0026 (13) −0.0013 (12)
C3 0.080 (2) 0.079 (2) 0.0341 (13) −0.0327 (17) −0.0068 (13) −0.0022 (13)
C4 0.0625 (16) 0.0627 (16) 0.0376 (12) −0.0268 (13) −0.0082 (11) −0.0086 (11)
C5 0.0402 (12) 0.0407 (12) 0.0345 (11) −0.0097 (9) −0.0058 (9) −0.0077 (9)
C6 0.0424 (12) 0.0420 (12) 0.0356 (11) −0.0106 (10) −0.0030 (9) −0.0105 (9)
C7 0.0418 (12) 0.0450 (12) 0.0319 (10) −0.0102 (10) −0.0087 (9) −0.0097 (9)
C8 0.0381 (11) 0.0397 (11) 0.0315 (10) −0.0072 (9) −0.0077 (8) −0.0093 (9)
C9 0.0434 (12) 0.0455 (12) 0.0359 (11) −0.0142 (10) −0.0071 (9) −0.0091 (9)
C10 0.0346 (11) 0.0436 (12) 0.0403 (12) −0.0059 (9) −0.0075 (9) −0.0152 (9)
C11 0.0588 (16) 0.0713 (18) 0.0417 (13) −0.0359 (14) 0.0026 (11) −0.0107 (12)
C12 0.106 (3) 0.0573 (18) 0.0569 (18) −0.0387 (18) −0.0014 (18) 0.0050 (14)
C13 0.098 (3) 0.060 (2) 0.082 (3) −0.0004 (19) −0.008 (2) 0.0036 (18)
N1 0.0432 (10) 0.0464 (11) 0.0345 (9) −0.0159 (9) −0.0060 (8) −0.0085 (8)
O1 0.0756 (13) 0.0754 (13) 0.0335 (9) −0.0392 (11) −0.0177 (8) 0.0004 (8)
S1 0.0471 (3) 0.0495 (3) 0.0328 (3) −0.0148 (3) −0.0131 (2) −0.0066 (2)
S2 0.0547 (4) 0.0703 (4) 0.0517 (4) −0.0268 (3) −0.0135 (3) −0.0194 (3)
Br1 0.0796 (2) 0.0688 (2) 0.0663 (2) −0.04359 (17) 0.00513 (15) −0.01814 (15)

Geometric parameters (Å, º)

C1—C6 1.374 (3) C8—S1 1.749 (2)
C1—C2 1.381 (4) C9—O1 1.213 (3)
C1—Br1 1.896 (2) C9—N1 1.394 (3)
C2—C3 1.380 (4) C10—N1 1.372 (3)
C2—H2 0.9300 C10—S2 1.631 (2)
C3—C4 1.374 (4) C10—S1 1.739 (2)
C3—H3 0.9300 C11—N1 1.453 (3)
C4—C5 1.401 (3) C11—C12 1.489 (5)
C4—H4 0.9300 C11—H11A 0.9700
C5—C6 1.401 (3) C11—H11B 0.9700
C5—C7 1.447 (3) C12—C13 1.283 (5)
C6—H6 0.9300 C12—H12 0.9300
C7—C8 1.345 (3) C13—H13A 0.9300
C7—H7 0.9300 C13—H13B 0.9300
C8—C9 1.472 (3)
C6—C1—C2 121.4 (2) C9—C8—S1 109.66 (16)
C6—C1—Br1 119.79 (18) O1—C9—N1 122.5 (2)
C2—C1—Br1 118.8 (2) O1—C9—C8 127.0 (2)
C3—C2—C1 118.7 (2) N1—C9—C8 110.44 (18)
C3—C2—H2 120.7 N1—C10—S2 126.32 (19)
C1—C2—H2 120.7 N1—C10—S1 110.91 (16)
C4—C3—C2 121.1 (3) S2—C10—S1 122.77 (14)
C4—C3—H3 119.5 N1—C11—C12 113.0 (2)
C2—C3—H3 119.5 N1—C11—H11A 109.0
C3—C4—C5 120.6 (2) C12—C11—H11A 109.0
C3—C4—H4 119.7 N1—C11—H11B 109.0
C5—C4—H4 119.7 C12—C11—H11B 109.0
C6—C5—C4 118.1 (2) H11A—C11—H11B 107.8
C6—C5—C7 117.89 (19) C13—C12—C11 127.9 (3)
C4—C5—C7 124.0 (2) C13—C12—H12 116.1
C1—C6—C5 120.2 (2) C11—C12—H12 116.1
C1—C6—H6 119.9 C12—C13—H13A 120.0
C5—C6—H6 119.9 C12—C13—H13B 120.0
C8—C7—C5 130.5 (2) H13A—C13—H13B 120.0
C8—C7—H7 114.8 C10—N1—C9 116.30 (19)
C5—C7—H7 114.8 C10—N1—C11 123.3 (2)
C7—C8—C9 120.37 (19) C9—N1—C11 120.27 (19)
C7—C8—S1 129.97 (18) C10—S1—C8 92.61 (11)

Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C7—H7···O1i 0.93 2.42 3.310 (3) 159

Symmetry code: (i) −x+1, −y+1, −z+2.

Footnotes

Supporting information for this paper is available from the IUCr electronic archives (Reference: SU5249).

References

  1. Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
  2. Burnett, M. N. & Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Tennessee, USA.
  3. Capan, G., Ulusoy, N., Ergenç, N., Cevdet Ekinci, A. & Vidin, A. (1996). Farmaco, 51, 729–732. [PubMed]
  4. El Ajlaoui, R., Rakib, E. M., Chigr, M., Saadi, M. & El Ammari, L. (2015). Acta Cryst. E71, o906–o907. [DOI] [PMC free article] [PubMed]
  5. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
  6. Insuasty, B., Gutie’rrez, A., Quiroga, J., Abonia, R., Nogueras, M., Cobo, J., Svetaz, L., Raimondi, M. & Zacchino, S. (2010). Arch. Pharm. 343, 48–53. [DOI] [PubMed]
  7. Kawakami, M., Koya, K., Ukai, T., Tatsuta, N., Ikegawa, A., Ogawa, K., Shishido, T. & Chen, L. B. (1998). J. Med. Chem. 41, 130–142. [DOI] [PubMed]
  8. Kesel, A. J. (2003). Biochem. Biophys. Res. Commun. 300, 793–799. [DOI] [PubMed]
  9. Momose, Y., Meguro, K., Ikeda, H., Hatanaka, C., Oi, S. & Sohda, T. (1991). Chem. Pharm. Bull. 39, 1440–1445. [DOI] [PubMed]
  10. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  11. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  12. Sortino, M., Delgado, P., Juárez, S. F., Quiroga, J., Abonía, R., Insuasty, B., Nogueras, M., Rodero, L., Garibotto, F. M., Enriz, R. D. & Zacchino, S. A. (2007). Bioorg. Med. Chem. 15, 484–494. [DOI] [PubMed]
  13. Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
  14. Tomasić, T. & Masic, L. P. (2009). Curr. Med. Chem. 16, 1596–1629. [DOI] [PubMed]
  15. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249sup1.cif

e-71-o1010-sup1.cif (785.6KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249Isup2.hkl

e-71-o1010-Isup2.hkl (333.1KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015022884/su5249Isup3.cml

. DOI: 10.1107/S2056989015022884/su5249fig1.tif

A view of the mol­ecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

a . DOI: 10.1107/S2056989015022884/su5249fig2.tif

A view along the a axis of the crystal packing of the title compound, showing the hydrogen bonds as dashed lines (see Table 1).

CCDC reference: 1439611

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES